Report Content
Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market scope & definitions
1.3 Base estimates & working
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Mammography systems industry 3600 synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Product trends
2.1.3 Technology trends
2.1.4 End-use trends
2.1.5 Regional trends
Chapter 3 Mammography Systems Industry Insights
3.1 Industry landscape, 2018 – 2032
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing incidence of breast cancer across the globe
3.2.1.2 Rising awareness about breast cancer screening and early detection in developed countries
3.2.1.3 Rising government funding for breast cancer screening tests in developed countries
3.2.1.4 Technological advancement in developed countries
3.2.2 Industry pitfalls & challenges
3.2.2.1 High capital investment
3.2.2.2 False-negative result
3.3 Growth potential analysis
3.3.1 By product
3.3.2 By technology
3.3.3 By end-use
3.4 COVID-19 impact analysis
3.5 Regulatory landscape
3.5.1 U.S.
3.5.2 Europe
3.6 Reimbursement landscape
3.6.1 U.S.
3.6.2 Europe
3.7 Technology landscape
3.8 Pricing analysis
3.9 Porter’s analysis
3.10 PESTEL analysis
Chapter 4 Competitive Landscape, 2021
4.1 Introduction
4.1.1 GE Healthcare
4.1.2 Siemems Healthineers
4.1.3 Hologic
4.1.4 Fujifilm Holdings Corporation
4.2 Competitive dashboard, 2021
4.3 Company matrix analysis, 2021
4.4 Company share analysis, 2021
4.5 Competitive analysis of major market players
4.6 Competitive positioning matrix
4.7 Strategic outlook matrix
Chapter 5 Mammography Systems Market, By Product
5.1 Key segment trends
5.2 Analog systems
5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3 Full field digital mammography (FFDM)
5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4 Breast tomosynthesis
5.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 6 Mammography Systems Market, By Technology
6.1 Key segment trends
6.2 Screen film
6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3 2D mammography
6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.4 3D mammography
6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.5 Others
6.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 7 Mammography Systems Market, By End-use
7.1 Key segment trends
7.2 Hospitals
7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.3 Ambulatory surgical centers
7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.4 Others
7.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 8 Mammography Systems Market Market, By Region
8.1 Key regional trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Poland
8.3.7 Switzerland
8.3.8 Sweden
8.3.9 Denmark
8.3.10 The netherlands
8.3.11 Belgium
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Indonesia
8.4.7 Thailand
8.4.8 Vietnam
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Chile
8.5.5 Colombia
8.6 Middle East & Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Israel
8.6.5 Iran
Chapter 9 Company Profiles
9.1 GE Healthcare
9.2 Analogic Corporation
9.3 Canon Medical Systems Corporation (Toshiba Medical Systems Corporation)
9.4 Carestream Health, Inc.
9.5 Delphinus Medical Technologies
9.6 Fujifilm Holdings Corporation
9.7 Hologic
9.8 IMS Giotto S.P.A.
9.9 Konica Minolta, Inc.
9.10 Koninklijke Philips N.V.
9.11 NP JSC Amico
9.12 Planmed Oy
9.13 Siemens Healthineers
